Agren, H. (1980) Symptom patterns in unipolar and bipolar depression correlating with monoamine metabolities in the cerebrospinal fluid: II. Suicide. Psychiatric Research, 3, 225–236.
Blier, P., de Montigny, C. & Chaput, Y. (1990) A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence. Journal of Clinical Psychiatry, 51, 14–20.
Charney, D. S., Delgado, P. L., Price, L. H.
et al (1991) The receptor sensitivity hypothesis of antidepressant action. In The Role of Serotonin in Psychiatric Disorders (eds Brown, S.-L. & van Praag, H. M.) pp. 27–56. New York: Brunner/Mazel.
Delgado, P.L., Charney, D. S., Price, L. H.
et al (1990) Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant induced remission by rapid depletion of plasma tryptophan. Archives of General Psychiatry, 47, 411–418.
Dinan, T. G. (1994). Glucocorticoids and the genesis of depressive illness. A psychobiological model. British Journal of Psychiatry, 164, 365–371.
Drevets, W. C. (1998) Functional neuroimaging studies of depression: the anatomy of melancholia. Annual Review of Medicine, 49, 341–361.
Duman, R. S., Henninger, G. R. & Nestler, E. J. (1997) A molecular and cellular theory of depression. Archives of General Psychiatry, 54, 597–606.
Earley, B., Glennon, M., Lally, M.
et al (1994) Autoradiographic distribution of cholinergic nuscarinic receptors and serotonin2 receptors in olfactory bulbectomized (OB) rats after chronic treatment with mianserin and desipramine. Human Psychopharmacology, 9, 397–407.
Janowsky, D. S., Risch, S. C., Kennedy, B.
et al (1986) Central muscarinic effects of physostigmine on mood, cardiovascular function, pituitary and adrenal neuroendocrine release. Psychopharmacology, 89, 150–154.
Kitayama, I., Yaga, T., Kayahara, T. J.
et al (1997) Long-term stress degenerates, but imipramine regenerates, noradrenergic axons in the rat cerebral cortex. Biological Psychiatry, 42, 687–696.
Leonard, B. E. (1986) Neurotransmitter receptors, endocrine response and the biological substrates of depression: a review. Human Psychopharmacology, 1, 3–18.
Leonard, B. E. (1994a) Biological strategies for the development of antidepressants. CNS Drugs, 1, 285–304.
Leonard, B. E. (1994b) Effect of antidepressants on specific neurotransmitters: are such effects relevant to their therapeutic action? In Handbook of Depression and Anxiety – A Biological Approach (eds den Boer, J. A. & Sitzen, J. M. A.) pp. 379–404. New York: Marcel Dekker.
Lesser, I. M., Mena, I. & Boone, K.B. (1994) Reduction of cerebral blood flow in older depressed patients. Archives in General Psychiatry, 51, 677–686.
Mansbach, R. S., Brooks, E. N. & Chen, Y. L. (1997) Antidepressant-like effects of CP-154, 526, a selective CRF receptor antagonist. European Journal of Pharmacology, 323, 21–26.
McAskill, R., Mir, S. & Taylor, D. (1998) Pindolol augmentation of antidepressant therapy. British Journal of Psychiatry, 173, 203–208.
Nugent, D. F. & Leonard, B. E. (1998) Platelet abnormalities in depression. Journal of Serotonin Research, 4, 251–266.
O'Keane, V., O'Flynn, K., Lucey, J.
et al (1992) Pyridostigmine induced growth hormone responses in healthy and depressed subjects – evidence for cholinergic supersensitivity in depression. Psychological Medicine, 22, 55–60.
Racagni, G., Tinelli, D. & Bianchi, E. (1991) cAMP dependent binding proteins and endogneous phosphorylation after antidepressant treatment. In Hydroxytryptamine in Psychiatry (eds Sandler, M., Coppen, A. & Hartnet, S.) (5th edn), pp. 116–123. Oxford: Oxford Medical Publications.
Reynolds, I. J. & Miller, R. J. (1988) Tricyclic antidepressants block N-methyl-D-aspartate receptor: similarities to the action of zinc. British Journal of Pharmacology, 95, 95–102.
Siuciak, J. A., Lewis, D., Wiegand, S. J.
et al (1996) Antidepressant like effect of brain derived neutrophic factor. Pharmacology, Biochemistry and Behavior, 56, 131–137.
Song, C. & Leonard, B. E. (1995) The effect of olfactory bulbectomy in the rat, alone or in combination with antidepressants on immune function. Human Psychopharmacology, 10, 7–18.
Tome, M. B., Isaac, M.T., Harte, R.
et al (1997) Paroxetine and pindolol: a randomized trial of serotonergic autoreceptor blockade in the reduction of antidepressant latency. International Clinical Psychopharmacology, 12, 81–89.
World Health Organization Mental Health Collaborating Centres (1989) Pharmacotherapy of depressive disorders: a consensus statement. Journal of Affective Disorders, 17, 197–198.
Wong, K. L., Bruch, R. C. & Farbman, A. I. (1991) Amitriptyline-mediated inhibition of neurite outgrowth from chick embryonic cerebral explants involves a reduction in adenylate cyclase activity. Journal of Neurochemistry, 57, 1223–1230.
Willner, P. (1983) A conceptual framework for psychobiological synthesis. Biological Psychiatry, 18, 1447–1450.